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ST1 type; and in-turn evolved recently to become the
“epidemic” ST7 type. The virulence increased in the ST7
type with its ability to stimulate massive amounts of pro-
inﬂammatory cytokines that led to the Streptococcal toxic
shock like syndrome.
Based on the information generated, we proposed a two
stage theory for the pathogenic mechanism of S. suis. When
the pathogen enters the human body (bloodstream), stage
one is initiated showing communication between bacterial
cell wall components with the host immune system using
pattern recognition receptors such as Toll-like receptor 2
and CD14; and probably by using the two-component signal
transduction system acquired recently with the consequent
burst of pro-inﬂammatory cytokines. The ST7 S. suis would
have mutated to stimulate the host to produce massive
amount of cytokines such as TNF-a, IL-1b and interferon
gamma that regulate high production levels of other
cytokines such as IL-6 and IL-12, leading to the STSLS. If a
patient survives the ﬁrst stage, the pathogen may reach the
central nervous system traveling free in the circulation or
monoctye-associated to cause the meningitis. The clinical
signiﬁcance of these ﬁndings was to prevent sudden death
associated with ST7 or ST1 S. suis infections where the
treatment was initiated early during the acute phase of the
infection, specially for therapies to prevent or reduce the
risk of STSLS.
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Objective: To determine the prevalence of drug resistant
HIV-1 and the efﬁcacy of ﬁrst-line HAART regimens consisting
of generic NRTI and NNRTI among 339 study subjects in rural
areas of Hubei province, China.
Methods: Two cross-sectional studies were conducted
to investigate 150 HAART-naive (99 received subsequent
therapy) between 2003 and 2005 and 288 HAART-
experienced patients between 2006 and 2007. Patients’
CD4+ T-cell count and viral load were determined. HIV-1
pol gene fragments were ampliﬁed from patients’ plasma
by RT-PCR, subsequently sequenced and analyzed.
Results: 83.5% of the patients were from rural villages.
They were dominantly infected with subtype B′ HIV-1
(97.4%) through paid blood donation (64.6%) and related
blood transfusion (28.3%). We found that there was a
steady increase of CD4 count over time among treated
patients without detectable viral load (186/288, 64.6%).
There was, however, an increasing prevalence of NRTI and
NNRTI resistant mutations among patients with detected
viremia (102/288, 35.4%) after treatment for 3 6 (24.3%),
9 12 (57.1%) and 20 24 (63.3%) months, respectively. The
increasing rates were associated with signiﬁcant CD4 count
drop and viral load increase. Some patients also developed
multi-drug resistant mutants.
Conclusions: We report the ﬁrst HIV-1 drug resistance study
after two-years on HAART among Chinese patients living in
rural villages. Our data suggest that a signiﬁcant portion
of patients are failing ﬁrst-line regimens with a trend of
AIDS progression. It is therefore necessary to maximize
the drug adherence and to make affordable second-line
HAART regimens available immediately. Our results have
implications for implementing HAART in under-resourced
developing country settings.
I-22 Molecular epidemiology of drug resistant HIV-1 in
Hong Kong
W.C. Yam*. Department of Microbiology, The University of
Hong Kong, China
The combination antiretroviral therapy is referred as
Highly Active Antiretroviral Therapy (HAART) which inhibits
different pathways of HIV pathogenesis so that viral
replication can be effectively suppressed. Following the
introduction of HAART since late 90s, signiﬁcant decline in
morbidity, mortality and HIV/AIDS incidence was reported
in Hong Kong. To monitor the efﬁcacy of HAART, genotyping
resistance test (GRT) by PCR-sequencing of the viral pol
gene (PR codon 1 to RT codon 410) was used to study 1,015
samples collected from 830 HIV-1+ patients. Results showed
good concordance to clinical response among treatment
experienced patients. Primary resistance was detected
among 6.7% of the treatment naive samples and GRT also
revealed the predominant subtypes CRF01_AE (45.8%) and
B (41.2%) were followed by C (4.4%), CRF07_BC (1.7%),
A1 (1.3%), CRF08_BC (0.9%), CRF02_AG (0.6%), CRF06_cpx
(0.3%) and G (0.1%). Mutations D30N, G48V and I84V were
only detected in subtype B while V32I mutation was only
detected in CRF01_AE. Resistance associated with HAART
were detected among 10% treatment experienced patients
after 18 24 months on HAART in Hong Kong. Increasing
prevalence of the primary resistance in Hong Kong was
detected since 1997 without subtype preference. The
presence of primary resistance in treatment naive patients
indicates the need for GRT on pre- and post-treatment
samples, so that appropriate regimens for HAART can be
implemented. Phylogenetic analysis of the pol gene also
identiﬁed 3 major local clusters of CRF01_AE subtypes
and B subtypes which were clonally related to reference
sequences from major cities in China (Fujian, Pingxiang and
Nanning).
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The ﬁrst Thai AIDS case was imported in 1984, since then
approximately one million Thais have been infected with
HIV, and currently, the estimated prevalence of HIV infection
is about 1%. There were 5 consecutive epidemic waves
as follows: among male homosexuals (started 1985), rapid
surge in intravenous drug users (1988), followed by female
commercial sex workers (1989), their male clients (1990)
and lastly wives and newborn of the latter (1991). Most
HIV infection is transmitted via heterosexual activities. This
spreading of infection occurred rapidly and caused great
alarm to all people involved.
Fortunately, the Thai Government at that time has
recognized this problem and considered AIDS prevention
and control a high national priority, involving several
ministries: Education, Health, Interior, etc. Thailand has
successfully slowed down the epidemic. However, hundred
thousands of people have already been infected. Prior to
the HAART era, hundreds of HIV-infected people became ill
with opportunistic infections (OI) and hence the diagnosis
of AIDS with high mortality. From our experience during
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1990 94, after the diagnosis of OI, one-year survival
probability is only 59.8% (95%CI 52.0 67.7%). The most
common OI’s are tuberculosis (40 50%), cryptococcosis
(25 40%), Pneumocystis carinii pneumonia PCP (10 20%),
toxoplasmosis (5 10%) and salmonellosis (5 10%). In the
northern part of Thailand, where Penicillium marneffei
is endemic, this infection is as common as tuberculosis,
indicating the importance of local endemic infection to be
recognized as AIDS-deﬁning illnesses. Cryptococcosis carries
the worst prognosis with 1-year survival probability of 31.9%
(16.8 48.1%).
Since HAART became available and ﬁnancially supported
by Thai Government in 2001, the morbidity and mortality
of HIV-infected persons have decreased remarkably. OI’s
has decreased and people living with AIDS/HIV survive
much longer. The emergence of drug-resistant HIV has
posed problems since the second line drugs are much more
expensive and not many to choose from. In addition, this
group can transmit drug-resistant HIV causing primary drug-
resistant HIV infection which will make it more difﬁcult to
choose the proper regimen without genotyping the virus.
Thus, strong prevention and control program should remain
at top priority, to stop new infection and transmission.
I-24 HIV-speciﬁc T-cell responses in a cohort of slow
progressors in China
T. Dong*. WIMM, Oxford University, United Kingdom
Background: There is an urgent need for an effective
vaccine to prevent HIV-1 infection, and current efforts are
directed towards generating vaccine candidates that will
elicit a T-cell immune response to the virus.. No studies
to date have described mechanisms of HIV resistance or
delayed disease progression in Chinese cohorts. For both
the design and the evaluation of CTL-inducing vaccines it is
important to deﬁne immunodominant CTL epitopes for both
the prevailing HLA types and the most common viral strains
affecting that population. Morever, it is also important to
identify composite features of T-cell responses associated
with good outcome and T-cell epitopes that will generate
such beneﬁcial features.
Study cohort: Current studies are limited by the facts that
most of the study cohort subjects have been infected for
different lengths of time; infected with different viral
strains and have a diverse genetic background. In this
study, we have access to a unique village cohort of patients
(N = 407) who were involved in a plasma donation scheme
that became contaminated with clade B HIV-1 in the period
1994 1995. 137 premature adult deaths were recorded in
the village with symptoms compatible with HIV-1 disease
before 2003. Of the surviving patients, none were treated
before 2003: therefore the proportion of slow or non-
progressors is unusually high in this cohort (>50% had CD4
counts >200 in 2004).
Results: We found that HLA-A30 and B51 were strongly
associated with low viral load in this cohort. We investigated
the hypothesis that immunodominant T-cell responses to
conserved HIV-1 proteins restricted by these alleles could
be partially responsible for good control of virus. We used
ELISPOT assays to test for responses to overlapping Clade B
peptides spanning the whole viral proteome and to the 202
best characterised optimal epitopes from the Los Alamos
data base. We found broad T cell responses, especially
directed towards the gag protein, in patients with low
viral loads. The immunodominance hierarchy of epitopes
restricted by common HLA molecules in the cohort showed
very different patterns from a published acute cohort
(Altfeld, 2006). We have sequenced the gag and nef genes
from 97 patients and will present data to show that the loss
of certain responses in the chronic phase of infection might
be due to early selection of escape mutants.
Conclusion: We have identiﬁed a panel of immunodominant
T-cell responses restricted by common HLA alleles in a
Chinese slow progressor cohort. Identiﬁcation of the most
beneﬁcial responses will be particular important for future
vaccine design targeted to the Chinese population.
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To combat the HIV/AIDS epidemic in China, the National
Center for AIDS/STD Control and Prevention established the
Division of Treatment and Care in late 2001. The pilot for
the National Free ART Program began in Henan Province in
2002, and the program fully launched in 2003. Initially,
treatment efforts focused on patients infected through
illicit blood and plasma donations in the mid-1990s, and
subsequently expanded to include HIV-infected injection
drug users, commercial sex workers, pregnant women, and
children. The National Free ART Database was established
in late 2004, and includes data on current patients and
those who were treated before 2004. Over 50,000 adult and
pediatric patients have been treated thus far. Challenges
for the program include integration of drug treatment
services with ART, an under-resourced health care system,
co-infections, stigma, discrimination, drug resistance, and
procurement of second-line ART. The merging of national
treatment and care, epidemiologic, and drug resistance
databases will be critical for a better understanding of the
epidemic, earlier identiﬁcation of patients requiring ART,
and improved patient follow-up. The Free ART Program has
made considerable progress in providing the necessary care
and treatment for HIV-infected people in China and has
strong government support for continued improvement and
expansion.
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HBV is an enveloped, hepatotrophic, oncogenic
hepadnavirus that infects hepatocytes and leukocytes
of humans and chimpanzees. The clinicopathological
outcomes of HBV infection are determined by both
viral and host factors. HBV infects hepatocytes without
triggering apoptosis, altering hepatocyte gene expression
or inducing innate immune production of IFNa or IFNb.
Host determinants of outcomes are the quality, quantity,
kinetics and immunoregulation of the integrated innate
and adaptive immune responses. HBV subverts the innate
immune response by down-regulating (1) expression of MICA,
the primary ligand for the NKG2D receptors of NK cells and
(2) TLR1, 2, 4 and 6 transcripts in PBMC. In addition, HBV
persistence and disease progression is favored by the low
production of mannose binding lectin (MBL) and reduction
in the interferon-inducible APOBEC3 family of cytidine
deaminases that inhibit HBV replication and hypermutate
the HBV genome. Generation of polyclonal, multi-antigen-
speciﬁc CD4 T-cell and CD8 cytotoxic T lymphocytes (CTL)
is required for resolution of acute HBV infection through
the combined effects of HBV-speciﬁc cytolysis of infected
